• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚(新南威尔士州)的运动神经元病

Motor neuron disease in Australia (State of New South Wales).

作者信息

Lance J W, Enis J, Duckworth J W

出版信息

Clin Exp Neurol. 1977;14:42-50.

PMID:616608
Abstract

The case histories of 70 patients with typical motor neuron disease (MND) have been analysed to ascertain the natural history of the disease in Australia. The place of birth and residence during life of each patient has been sought to determine whether there is any 'clustering' of patients in the State of New South Wales. The mean age of onset was 55 years and mean duration of life from onset was 3 years 5 months. These figures are comparable with those from the USA and UK and Japan although the onset in Australia was later and the duration longer. The case history of 1 patient who is still living 38 years after the onset of the disease is described as there is no longer survival time recorded in the literature to our knowledge. Attention is drawn to muscle aches and cramps mentioned spontaneously by 27 of the 70 patients. These symptoms occurred at the onset of MND and often correlated with the site of onset of weakness. Weight loss averaged 1.6lb (0.7kg) per month in those patients in whom weight was recorded. The CSF protein was greater than 45mg/100ml, ranging up to 110mg/100ml, in 9 of 37 patients. The place of residence of patients bore no relation to known areas of increased manganese in the soil, and there was no evidence of 'clustering' of cases.

摘要

对70例典型运动神经元病(MND)患者的病历进行了分析,以确定澳大利亚该疾病的自然病程。已查明每位患者的出生地和一生中的居住地,以确定新南威尔士州是否存在患者“聚集”现象。发病的平均年龄为55岁,从发病起的平均寿命为3年5个月。这些数字与美国、英国和日本的数字相当,尽管澳大利亚的发病时间较晚,病程较长。描述了1例发病38年后仍在世患者的病历,据我们所知,文献中尚无更长的存活时间记录。值得注意的是,70例患者中有27例自发提到肌肉疼痛和痉挛。这些症状在运动神经元病发病时出现,且常与肌无力的发病部位相关。记录体重的患者体重平均每月下降1.6磅(0.7千克)。37例患者中有9例脑脊液蛋白大于45mg/100ml,最高可达110mg/100ml。患者的居住地与土壤中已知锰含量增加的地区无关,且没有病例“聚集”的证据。

相似文献

1
Motor neuron disease in Australia (State of New South Wales).澳大利亚(新南威尔士州)的运动神经元病
Clin Exp Neurol. 1977;14:42-50.
2
Motor neuron disease in the Rocky Mountain region.落基山脉地区的运动神经元病
West J Med. 1988 Apr;148(4):430-2.
3
[Survival in amyotrophic lateral sclerosis].[肌萎缩侧索硬化症的生存情况]
Srp Arh Celok Lek. 1997 Jan-Feb;125(1-2):19-23.
4
Clinical and epidemiological features of motor neuron disease in south-western Greece.希腊西南部运动神经元病的临床和流行病学特征
Acta Neurol Scand. 2005 Feb;111(2):108-13. doi: 10.1111/j.1600-0404.2004.00362.x.
5
Riluzole therapy for motor neurone disease: an early Australian experience (1996-2002).利鲁唑治疗运动神经元病:澳大利亚早期经验(1996 - 2002年)
J Clin Neurosci. 2006 Jan;13(1):78-83. doi: 10.1016/j.jocn.2004.04.011.
6
[Study of the onset and progression of peripheral neuropathy and hypertension in NIDDM].非胰岛素依赖型糖尿病患者周围神经病变与高血压的发病及进展研究
Minerva Med. 2000 Jan-Feb;91(1-2):1-15.
7
Motor neuron disease. Prognosis and epidemiology.运动神经元病。预后与流行病学。
Acta Neurol Scand. 1977 Oct;56(4):299-308.
8
Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease.新的阈值跟踪技术表明,皮质兴奋性过高是运动神经元疾病的早期特征。
Brain. 2006 Sep;129(Pt 9):2436-46. doi: 10.1093/brain/awl172. Epub 2006 Jul 10.
9
Metals in spinal cord tissue of patients dying of motor neuron disease.
Ann Neurol. 1979 Jul;6(1):21-4. doi: 10.1002/ana.410060105.
10
Spinal muscular atrophy: survival pattern and functional status.脊髓性肌萎缩症:生存模式与功能状态
Pediatrics. 2004 Nov;114(5):e548-53. doi: 10.1542/peds.2004-0668. Epub 2004 Oct 18.